Related Experiment Video
Updated: Jul 28, 2026

09:16
Air-sampled Filter Analysis for Endotoxins and DNA Content
Published on: March 7, 2016
A rapid test for endotoxin in whole blood
Summary
A new rapid whole blood test detects endotoxin using polymyxin B and red blood cells. This agglutination assay shows high correlation with the Limulus amoebocyte lysate test for diagnosing Gram-negative sepsis.
Area of Science:
- Biomedical Diagnostics
- Immunology
- Microbiology
Background:
- Endotoxins from Gram-negative bacteria are critical indicators of sepsis.
- Accurate and rapid detection of endotoxins is crucial for timely clinical intervention.
- Existing methods like the Limulus amoebocyte lysate (LAL) test can be time-consuming.
Purpose of the Study:
- To develop and evaluate a rapid whole blood agglutination test for endotoxin detection.
- To assess the correlation of the new test with established endotoxin detection methods.
- To explore the potential of this test for clinical management of Gram-negative infections.
Main Methods:
- Development of a reagent combining polymyxin B (PmB) with an anti-glycophorin antibody Fab fragment.
- Testing the reagent with whole blood, Gram-negative bacteria, bacterial culture supernatants, and purified endotoxin.
- Assessing red blood cell agglutination as an indicator of endotoxin presence.
- Correlating agglutination strength with endotoxin levels measured by the Limulus amoebocyte lysate (LAL) test.
Main Results:
- The developed reagent induced rapid red blood cell agglutination within two minutes in the presence of endotoxin.
- Agglutination was observed with whole blood from endotoxemic patients, Gram-negative bacteria, and purified endotoxin.
- A strong positive correlation (r = 0.83) was found between agglutination strength and LAL test results.
- The test demonstrated high sensitivity and specificity for endotoxin detection.
Conclusions:
- A novel, rapid whole blood agglutination test for endotoxin detection has been successfully developed.
- The test shows significant promise as a rapid diagnostic tool for Gram-negative bacterial infections and sepsis.
- This assay could potentially improve the clinical management of patients with Gram-negative sepsis by enabling faster diagnosis.

